PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,922,760 | +15.7% | 122,854 | +17.8% | 0.04% | +9.4% |
Q1 2023 | $4,254,769 | +5.6% | 104,258 | -0.1% | 0.03% | +3.2% |
Q4 2022 | $4,029,764 | -72.5% | 104,371 | -62.1% | 0.03% | -74.4% |
Q3 2022 | $14,651,000 | -13.4% | 275,451 | -5.1% | 0.12% | -6.2% |
Q2 2022 | $16,925,000 | -25.6% | 290,310 | -2.7% | 0.13% | -12.8% |
Q1 2022 | $22,761,000 | +6.7% | 298,236 | -15.9% | 0.15% | +9.6% |
Q4 2021 | $21,337,000 | +38.0% | 354,606 | +28.5% | 0.14% | +29.8% |
Q3 2021 | $15,459,000 | -12.9% | 276,047 | -5.6% | 0.10% | -10.3% |
Q2 2021 | $17,752,000 | -19.0% | 292,556 | -6.5% | 0.12% | -21.6% |
Q1 2021 | $21,927,000 | -13.0% | 312,844 | -25.7% | 0.15% | -19.6% |
Q4 2020 | $25,191,000 | +4.9% | 420,967 | +5.4% | 0.18% | -10.7% |
Q3 2020 | $24,007,000 | +130.5% | 399,319 | +101.2% | 0.21% | +123.9% |
Q2 2020 | $10,413,000 | +53.8% | 198,448 | -1.7% | 0.09% | +26.0% |
Q1 2020 | $6,772,000 | -15.6% | 201,981 | +14.0% | 0.07% | +17.7% |
Q4 2019 | $8,027,000 | +14.1% | 177,198 | -4.1% | 0.06% | +6.9% |
Q3 2019 | $7,032,000 | – | 184,720 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |